Fulcrum Therapeutics (FULC) Assets Average (2019 - 2025)
Historic Assets Average for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $221.8 million.
- Fulcrum Therapeutics' Assets Average fell 2260.18% to $221.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.8 million, marking a year-over-year decrease of 2260.18%. This contributed to the annual value of $259.2 million for FY2024, which is 702.61% up from last year.
- Latest data reveals that Fulcrum Therapeutics reported Assets Average of $221.8 million as of Q3 2025, which was down 2260.18% from $235.7 million recorded in Q2 2025.
- Fulcrum Therapeutics' 5-year Assets Average high stood at $310.7 million for Q2 2023, and its period low was $143.0 million during Q1 2021.
- For the 5-year period, Fulcrum Therapeutics' Assets Average averaged around $239.1 million, with its median value being $245.1 million (2024).
- Per our database at Business Quant, Fulcrum Therapeutics' Assets Average surged by 8048.62% in 2021 and then tumbled by 2260.18% in 2025.
- Fulcrum Therapeutics' Assets Average (Quarter) stood at $245.3 million in 2021, then fell by 3.27% to $237.2 million in 2022, then rose by 13.08% to $268.3 million in 2023, then grew by 0.59% to $269.9 million in 2024, then decreased by 17.79% to $221.8 million in 2025.
- Its Assets Average was $221.8 million in Q3 2025, compared to $235.7 million in Q2 2025 and $251.7 million in Q1 2025.